Abiopharma

News list

Niedzwiecki Daniel 🟡 adjusted position in 35.4K shares of Lantheus Holdings, Inc. (LNTH) at $76.31 Transaction Date: Mar 05, 2026 | Filing ID: 000125

Full text

News bot March 9, 2026, 9:06 p.m.
🔍 Niedzwiecki Daniel (Executive)

Company: Lantheus Holdings, Inc. (LNTH)

Report Date: 2026-03-05
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 36,692
- Total shares sold: 1,283
Detailed Transactions and Holdings:
- Acquired 36,692 shares of Common Stock (Direct)
  Date: 2026-03-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 120,659.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 1,283 shares of Common Stock at $76.31 per share (Direct)
  Date: 2026-03-05 | Code: F | equity_swap_involved: 0 | shares_owned_after: 119,376.00 | transaction_form_type: 4
Footnotes:
- F1: Consists of 18,346 restricted stock units that vest in equal installments over a three-year period and 18,346 Total Shareholder Return performance-based restricted stock units ("PSUs") that cliff vest following a three-year performance period. The amount of PSUs included in this Report reflects the target award; however, the ultimate award size can range from 0% to 200% of the target based on the actual performance achieved at the end of the performance period.
- REMARKS: Chief Administrative Officer, General Counsel and Corporate Secretary